Karolinska Development AB (publ): Karolinska Development's portfolio company Aprea Therapeutics acquires Atrin Pharmaceuticals
STOCKHOLM, SWEDEN, May 17 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company Aprea Therapeutics has completed the acquisition of the privately-held US-based biotechnology
Karolinska Institutet Johan Dighed Viktor Drvota Kd Aprea Atrin Atrin Pharmaceuticals Inc Karolinska Development Ab Nasdaq Stockholm
Source: finanznachrichten.de